Federal contract award
75A50122C00040
RESEARCH AND DEVELOPMENT FOR INCREASED AT-HOME SARS-COV-2 TEST SENSITIVITY & PERFORMANCE WITH 3M BIOAEROSOL SAMPLING DEVICE FOR AOI #11B: ENABLING TECHNOLOGIES TO SUPPORT HOME-BASED DIAGNOSTICS FOR SARS-COV-2 ACUTE INFECTION
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $750.0K |
| Current contract value | $750.0K |
| Potential contract value / ceiling | $750.0K |
| Start date | Sep 1, 2022 |
| Current end date | Feb 29, 2024 |
| Potential end date | Feb 29, 2024 |
| Latest award activity | Jun 24, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 24, 2025 | P00002 | $-0 | RESEARCH AND DEVELOPMENT FOR INCREASED AT-HOME SARS-COV-2 TEST SENSITIVITY & PERFORMANCE WITH 3M BIOAEROSOL SAMPLING DEVICE FOR AOI #11B: ENABLING TECHNOLOGIES TO SUPPORT HOME-BASED DIAGNOSTICS FOR SARS-COV-2 ACUTE INFECTION |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.